4D MOLECULAR THERAPEUTICS IN's ticker is FDMT and the CUSIP is 35104E100. A total of 101 filers reported holding 4D MOLECULAR THERAPEUTICS IN in Q2 2023. The put-call ratio across all filers is 1.67 and the average weighting 0.2%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 3,000,000 | $54,210,000 | 8.67% |
| Deep Track Capital, LP | 2,778,107 | $50,200,393 | 2.32% |
| BVF INC/IL | 4,007,413 | $72,413,953 | 2.02% |
| Casdin Capital, LLC | 1,070,000 | $19,334,900 | 1.69% |
| Eagle Health Investments LP | 437,911 | $7,913,052 | 1.48% |
| Novo Holdings A/S | 1,000,000 | $18,070,000 | 1.40% |
| GREAT POINT PARTNERS LLC | 350,000 | $6,324,500 | 1.24% |
| RA Capital Management | 3,069,531 | $55,466,425 | 1.05% |
| Opaleye Management Inc. | 221,700 | $4,006,119 | 0.96% |
| Soleus Capital Management, L.P. | 219,148 | $3,960,004 | 0.44% |
| VIKING GLOBAL INVESTORS LP | 4,787,914 | $86,517,606 | 0.35% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 650,000 | $11,745,500 | 0.25% |
| ArrowMark Colorado Holdings LLC | 1,031,398 | $18,637,362 | 0.20% |
| Perigon Wealth Management, LLC | 492,150 | $8,893,150 | 0.18% |
| Elmwood Wealth Management, Inc. | 19,800 | $357,786 | 0.17% |
| Ghisallo Capital Management LLC | 25,000 | $451,750 | 0.05% |
| Virtus ETF Advisers LLC | 4,923 | $88,959 | 0.05% |
| JANUS HENDERSON GROUP PLC | 2,838,882 | $51,276,601 | 0.03% |
| Ergoteles LLC | 35,922 | $649,111 | 0.03% |
| EcoR1 Capital, LLC | 66,978 | $1,210,292 | 0.03% |
External links
This page lists 4D MOLECULAR THERAPEUTICS IN's shareholders in Q2 2023. To view 4D MOLECULAR THERAPEUTICS IN's shareholder history, click here.